{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:08:27Z","timestamp":1793606907719,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"am","delay-in-days":361,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["OC130500"],"award-info":[{"award-number":["OC130500"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ygyno.2018.11.033","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T02:30:27Z","timestamp":1543545027000},"page":"426-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["The fallopian tube, \u201cprecursor escape\u201d and narrowing the knowledge gap to the origins of high-grade serous carcinoma"],"prefix":"10.1016","volume":"152","author":[{"given":"Thing Rinda","family":"Soong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke E.","family":"Howitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa R.","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Crum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2018.11.033_bb0005","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0010","series-title":"Screening for Ovarian Cancer: An Updated Evidence Review for the U.S. Preventive Services Task Force [Internet]","author":"Henderson","year":"2018"},{"key":"10.1016\/j.ygyno.2018.11.033_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.humpath.2018.06.018","article-title":"Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics","volume":"80","author":"Prat","year":"2018","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0020","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L","article-title":"Early de novo ovarian carcinoma. A study of fourteen cases","volume":"73","author":"Bell","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2018.11.033_bb0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/PGP.0000000000000120","article-title":"Two types of ovarian cortical inclusion cysts: proposed origin and possible role in ovarian serous carcinogenesis","volume":"34","author":"Banet","year":"2015","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PGP.0b013e3181f45f3e","article-title":"The origin of ovarian carcinomas: a unifying hypothesis","volume":"30","author":"Auersperg","year":"2011","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0035","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2013.03.021","article-title":"Ovarian surface epithelium as a source of ovarian cancers: unwarranted speculation or evidence-based hypothesis?","volume":"130","author":"Auersperg","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0040","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2559.1995.tb01528.x","article-title":"p53 protein expression in putative precursor lesions of epithelial ovarian cancer","volume":"27","author":"Hutson","year":"1995","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.ygyno.2018.11.033_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010358","article-title":"Genetic analysis of the early natural history of epithelial ovarian carcinoma","volume":"5","author":"Pothuri","year":"2010","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ygyno.2018.11.033_bb0050","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1002\/cncr.11848","article-title":"Prophylactic oophorectomy: a morphologic and immunohistochemical study","volume":"98","author":"Schlosshauer","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2018.11.033_bb0055","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0060","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/1097-0142(20000715)89:2<383::AID-CNCR25>3.0.CO;2-T","article-title":"Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes","volume":"89","author":"Barakat","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2018.11.033_bb0065","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nature11979","article-title":"Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche","volume":"495","author":"Fleskin-Nikitin","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2018.11.033_bb0070","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/cncr.11847","article-title":"Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies","volume":"98","author":"Roland","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2018.11.033_bb0075","first-page":"1","article-title":"Pathophysiological dynamics of human ovarian surface epithelial cells in epithelial ovarian carcinogenesis","volume":"242","author":"Okamura","year":"2005","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0080","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1210\/en.2014-1977","article-title":"The ovary is an alternative site of origin for high-grade serous ovarian cancer in mice","volume":"156","author":"Kim","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.ygyno.2018.11.033_bb0085","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41467-017-01217-9","article-title":"Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma","volume":"8","author":"Ducie","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080314","article-title":"Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomes","volume":"8","author":"Merritt","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2018.11.033_bb0095","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1593\/neo.91948","article-title":"Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer","volume":"12","author":"Lawrenson","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.ygyno.2018.11.033_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010358","article-title":"Genetic analysis of the early natural history of epithelial ovarian carcinoma","volume":"5","author":"Pothuri","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2018.11.033_bb0105","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1447-0756.2010.01272.x","article-title":"Development of the genital ducts and external genitalia in the early human embryo","volume":"36","author":"Saijad","year":"2010","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00004347-199401000-00009","article-title":"The secondary mullerian system revisited","volume":"13","author":"Lauchlan","year":"1994","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0115","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","article-title":"The cell of origin of ovarian epithelial tumours","volume":"9","author":"Dubeau","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2559.1984.tb02336.x","article-title":"Peritoneal epithelial lesions associated with proliferative serous tumours of ovary","volume":"8","author":"McCaughey","year":"1984","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2018.11.033_bb0125","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ygyno.2013.12.015","article-title":"Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma","volume":"132","author":"Bahar-Shany","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng1294-399","article-title":"Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families","volume":"8","author":"Friedman","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.1999.5623","article-title":"Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations","volume":"76","author":"Zweemer","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0145","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/modpathol.2016.238","article-title":"Serous tubal intraepithelial neoplasia: the concept and its application","volume":"30","author":"Meserve","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0150","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.AOG.0000187892.78392.3f","article-title":"BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?","volume":"106","author":"Cass","year":"2005","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0155","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2016.08.336","article-title":"Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers","volume":"143","author":"Zakhour","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0160","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ygyno.2013.12.009","article-title":"Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations","volume":"132","author":"Conner","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0165","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2013.01.029","article-title":"Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy","volume":"129","author":"Powell","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0170","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ygyno.2015.09.018","article-title":"Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): a comprehensive review","volume":"139","author":"Patrono","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000114","article-title":"The preclinical natural history of serous ovarian cancer: defining the target for early detection","volume":"6","author":"Brown","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0180","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/PAS.0000000000000353","article-title":"Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas","volume":"39","author":"Gilks","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0190","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/1471-0528.14543","article-title":"Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review","volume":"124","author":"Chen","year":"2017","journal-title":"Brit. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2015.10.022","article-title":"Primary site assignment in tubo-ovarian high-grade serous carcinoma: consensus statement on unifying practice worldwide","volume":"141","author":"Singh","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0200","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/modpathol.2010.119","article-title":"High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression","volume":"23","author":"Roh","year":"2010","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0205","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/PAS.0000000000000369","article-title":"Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma","volume":"39","author":"Howitt","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0210","article-title":"Evidence for lineage continuity between early serous proliferations (ESPs) in the fallopian tube and disseminated high-grade serous carcinomas","volume":"25","author":"Soong","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0215","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/jamaoncol.2015.1618","article-title":"Next-generation sequencing of tubal intraepithelial carcinomas","volume":"1","author":"McDaniel","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0220","article-title":"Evidence of a monoclonal origin for bilateral serous tubal intraepithelial neoplasia","author":"Meserve","year":"2018","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0225","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0230","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0235","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/PGP.0b013e31823b8831","article-title":"Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma","volume":"31","author":"Vang","year":"2012","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0240","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/PGP.0b013e31827f3fa8","article-title":"Precursor lesions and prognostic factors in primary peritoneal serous carcinoma","volume":"32","author":"Lee","year":"2013","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0245","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1158\/1078-0432.CCR-04-2509","article-title":"Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon","volume":"11","author":"Marquez","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0250","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0255","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/modpathol.2010.171","article-title":"The impact of tissue block sampling on the detection of p53 signatures in fallopian tubes from women with BRCA 1 or 2 mutations (BRCA+) and controls","volume":"24","author":"Mehra","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0260","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s13224-017-1009-0","article-title":"Serous tubal carcinogenesis: the recent concept of origin of ovarian, primary peritoneal and fallopian tube high-grade serous carcinoma","volume":"67","author":"Kar","year":"2017","journal-title":"J. Obstet. Gynaecol. India"},{"key":"10.1016\/j.ygyno.2018.11.033_bb0265","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma\u2014evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0270","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/0046-8177(95)90203-1","article-title":"Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation","volume":"26","author":"Ambros","year":"1995","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0275","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0b013e318202772e","article-title":"A proposed model for endometrial serous carcinogenesis","volume":"35","author":"Zheng","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0280","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/modpathol.2008.197","article-title":"Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma","volume":"22","author":"Jarboe","year":"2009","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0285","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0290","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/path.4516","article-title":"Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden","volume":"236","author":"Anglesio","year":"2015","journal-title":"J. Pathol."},{"issue":"6","key":"10.1016\/j.ygyno.2018.11.033_bb0295","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv428","article-title":"Synchronous endometrial and ovarian carcinomas: evidence of clonality","volume":"108","author":"Anglesio","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0300","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nm1173","article-title":"Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer","volume":"11","author":"Dinulescu","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0305","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ygyno.2018.05.011","article-title":"Hereditary ovarian cancer clinical study group. Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation","volume":"150","author":"Kotsopoulos","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"10022","key":"10.1016\/j.ygyno.2018.11.033_bb0310","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian cancer screening and mortality in the UK collaborative trial of ovarian Cancer screening (UKCTOCS): a randomised controlled trial","volume":"387","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2018.11.033_bb0315","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2008.07.018","article-title":"Risk factors for a serous cancer precursor (\u201cp53 signature\u201d) in women with inherited BRCA mutations","volume":"111","author":"Saleemuddin","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0320","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1158\/1940-6207.CAPR-18-0009","article-title":"Fallopian tube lesions in women at high risk for ovarian Cancer: a multicenter study","volume":"11","author":"Visvanathan","year":"2018","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.ygyno.2018.11.033_bb0325","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ygyno.2009.03.023","article-title":"Acquisition of a second mutation of the Tp53 alleles immediately precedes epithelial morphological transformation in ovarian tumorigenicity","volume":"114","author":"Cai","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0330","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2018.11.033_bb0335","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2014.02.030","article-title":"Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers","volume":"133","author":"Holman","year":"2014","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818314537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818314537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:41:23Z","timestamp":1758771683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818314537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0090825818314537"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.11.033","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734573987.793556132","asserted-by":"object"}]},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The fallopian tube, \u201cprecursor escape\u201d and narrowing the knowledge gap to the origins of high-grade serous carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.11.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}